← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2005Last known activity
Jan 31, 2020
Acquired by Linical Co., Ltd. on Jul 1, 2018
Timeline
2000s
- Jun 1, 2004
Accelovance— Founded
2010s
- Dec 2, 2015
Clinquest, Inc.— Acquired
- Jul 1, 2018
Linical Co., Ltd.— Acquired By
Drugs by trial phase (29 distinct, 22 trials)
Phase 3 (1 own, 1 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Anthrax
- Breast Neoplasms
- Carcinoma
- Carcinoma, Renal Cell
- Fever
- Hemorrhagic Fever, Ebola
- Herpes Labialis
- Influenza, Human
- Influenza in Birds
- Lice Infestations
- Mite Infestations
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Parasitic Diseases
- Prostatic Neoplasms
- Typhoid Fever
- Urinary Bladder Neoplasms
- Virus Diseases
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (22)
- NCT04250597Lead sponsorPhase 1Jan 31, 2020
- NCT03781063CollaboratorPhase 2May 31, 2019
- NCT03672240Study chairPhase 1/Phase 2Oct 31, 2018
- NCT03569280CollaboratorPhase 1Sep 30, 2018
- NCT03192306CollaboratorPhase 2Jul 5, 2017
- NCT03033316CollaboratorPhase 1/Phase 2Jan 1, 2017
- NCT03120832CollaboratorPhase 1Dec 1, 2016
- NCT02661958Study chairPhase 2May 1, 2016
- NCT02661958CollaboratorPhase 2May 1, 2016
- NCT02718469CollaboratorPhase 1Dec 22, 2015
- NCT02434276CollaboratorPhase 2May 1, 2015
- NCT02432846CollaboratorPhase 2Apr 1, 2015
- NCT02115815Overall official - principal investigatorPhase 1Apr 1, 2014
- NCT02060903CollaboratorPhase 3Feb 1, 2014
- NCT02062060CollaboratorPhase 3Feb 1, 2014
Details
- Founded
- Washington DC, US Jun 1, 2004
- Last known activity
- Jan 31, 2020